Innovation, Economics, and Pricing in the Life Science Industry

18 Wake Forest J. Bus. & Intell. Prop. L. 568

The thesis of this paper is that the development of novel medical
interventions in areas of continuing unmet medical need increasingly
requires—and is enabled by—broad cross-sectorial interaction and
collaboration involving academic research, the public sector, non-
governmental organizations and foundations, and private sector
investment and industry. This is not a novel or controversial thesis but
a descriptive one that recognizes and reinforces the productive character
of these symbiotic relationships and suggests that extending the model
is a way forward in the evolving new era of medical innovation.